+41.1%
GSK vs TW
+30.1%
+11.1%
-37.6%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 5y.
| Period | Portfolio | TW | Excess | Alpha |
|---|---|---|---|---|
| 1D | -0.1% | -0.3% | +0.2% | -0.1% |
| 7D | -5.3% | -4.8% | -0.5% | -4.7% |
| 30D | -3.7% | +5.3% | -9.0% | -4.3% |
| 3M | -7.3% | +19.3% | -26.5% | -9.3% |
| 6M | -4.2% | +18.8% | -23.0% | -6.5% |
| YTD | +0.9% | +18.0% | -17.1% | -1.9% |
| 1Y | +7.3% | +18.9% | -11.6% | +4.2% |
| 3Y | +52.7% | +36.9% | +15.8% | +44.9% |
| All | +41.1% | +30.1% | +11.1% | +30.7% |
Cumulative growth
Daily Returns
Daily percentage return beside TW.
Daily Out/Under-Performance
Portfolio return minus TW return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × TW return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 5y: compounded portfolio wealth divided by compounded TW wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
5y analysis · Full analysis span regression · 6 months rolling